Capital Investment Advisory Services, LLC Ionis Pharmaceuticals Inc Transaction History

Capital Investment Advisory Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 23, 2019	SELL	$52.92 - $81.17 $89,434 - $137,177	-1,690 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$43.37 - $59.54 $73,295 - $100,622	1,690 New	1,690 $91,000
Q3 2018 Oct 30, 2018	SELL	$42.88 - $53.7 $369,153 - $462,303	-8,609 Closed	0 $0
Q2 2018 Aug 01, 2018	SELL	$40.53 - $50.7 $100,919 - $126,243	-2,490 Reduced 22.43%	8,609 $359,000
Q1 2018 Apr 30, 2018	SELL	$44.08 - $55.05 $212,906 - $265,891	-4,830 Reduced 30.32%	11,099 $489,000
Q4 2017 Jan 31, 2018	SELL	$50.3 - $64.39 $86,767 - $111,072	-1,725 Reduced 9.77%	15,929 $801,000
Q3 2017 Oct 31, 2017	BUY	$45.56 - $59.57 $804,316 - $1.05 Million	17,654	17,654 $895,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.